Cover Image
市場調查報告書

經皮藥物輸送的革新

Innovations in Transdermal Drug Delivery

出版商 Frost & Sullivan 商品編碼 600231
出版日期 內容資訊 英文 61 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
經皮藥物輸送的革新 Innovations in Transdermal Drug Delivery
出版日期: 2017年12月29日 內容資訊: 英文 61 Pages
簡介

本報告提供全球經皮藥物輸送的技術創新趨勢調查,彙整經皮藥物輸送概要,特徵,優點,主要的技術趨勢,主要的適應症的影響,成長機會,成功必要條件分析等資料。

第1章 摘要整理

第2章 產業概要

  • 經皮藥物遞送:一種有前途的藥物遞送方法
  • 經皮給藥技術的進展
  • 技術創新解決傳統的經皮傳遞挑戰
  • 主動和被動經皮給藥技術

第3章 技術概要·技術趨勢

  • 經皮藥物輸送的磨皮
    • 企業的革新
    • 大學的革新
  • 電力技術支援的經皮藥物輸送
    • 離子透入治療疼痛和偏頭痛的經皮系統
  • 經皮藥物輸送的超音波
  • 方便易用的微針貼片,具有傳統注射針的功效
    • 使用微針的不同的遞送策略
    • 固體和液體劑量微針藥物遞送裝置
    • 用於流感疫苗接種的溶解微針貼劑技術
    • 可定制的金屬基空心微針技術
    • 專有的微針製造技術
    • 可溶性微針貼劑提供化學治療劑治療皮膚癌
    • 溶化微針貼片化妝品應用
    • 最近的抗衰老微針專利
    • 近期專利分析的微觀創新
    • 最近的大學微針專利

第4章 影響的評估·分析

  • 經皮藥物輸送解決方案:疼痛·神經症書·荷爾蒙症狀等的影響
    • 第一代臨床試驗的評估
    • 第二代臨床試驗的評估
    • 第三代臨床試驗的評估
    • 各代主要的經皮治療臨床試驗
    • 產業內的聯盟·合作
    • 大學專利的微針頭技術
    • 企業專利的經皮技術
    • 資金籌措分析等

第5章 成長機會·策略分析

  • 經皮藥物輸送產業的革新生態系統:主要創新者
  • 成長機會
    • 先進微針頭
    • 經皮遺傳基因遞送
    • 智慧經皮吸收貼片
  • 技術藍圖
  • 先進經皮藥物輸送技術的融合
  • 新的十字叢集技術:為未來的產業帶來創新
  • 促進產業成長的策略性建議

第6章 聯繫資訊

目錄
Product Code: D807

Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry

With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has several inherent limitations which can be overcome by technology innovations such as skin ablation (laser, radio frequency), electrical (iontophoresis and electroportation), mechanical (microneedle) methods. This research report focuses different technology innovations, key innovators in this space, industry trends, and impact across different therapeutic areas.

Table of Contents

1.0. Executive Summary

  • 1.1. Scope of the Research
  • 1.2. Research Methodology
  • 1.2. Research Methodology (continued)
  • 1.3. Key Findings

2.0. Industry Overview

  • 2.1. Transdermal Drug Delivery: A Promising Method of Drug Delivery
  • 2.2. Evolution of Transdermal Drug Delivery Technologies
  • 2.3. Technology Innovations Addressing Conventional Transdermal Delivery Challenges
  • 2.4. Active and Passive Transdermal Drug Delivery Technologies

3.0. Technology Snapshot and Trends

  • 3.1. Skin Ablation for Transdermal Drug Delivery
    • 3.1.1. Company Skin Ablation Innovations for Transdermal Drug Delivery
    • 3.1.2. University Skin Ablation Innovations for Transdermal Drug Delivery
  • 3.2. Transdermal Drug Delivery Assisted by Electrical Technologies
    • 3.2.1. Iontophoretic Transdermal System for Managing Pain and Migraine
  • 3.3. Ultrasound for Transdermal Drug Delivery
  • 3.4. Convenient, Easy-to-Use Microneedle Patch with Efficacy of Conventional Needle Injection
    • 3.4.1. Different Delivery Strategies Using Microneedles
    • 3.4.2. Solid and Liquid Dose Microneedle Drug Delivery Device
    • 3.4.3. Dissolving Microneedle Patch Technology for Flu Vaccination
    • 3.4.4. Customizable, Metal-based Hollow Microneedle Technology
    • 3.4.5. Proprietary Microneedle Fabrication Technology
    • 3.4.6. Dissolvable Microneedle Patch to Deliver Chemotherapeutic Agent for Treating Skin Cancer
    • 3.4.7. Dissolving Microneedle Patches for Cosmetic Applications
    • 3.4.8. Recent Microneedle Patents for Antiaging
    • 3.4.9. Recent Microneedle Innovations from Patent Analysis
    • 3.4.10. Recent Microneedle Patents from Universities

4.0. Impact Assessment and Analysis

  • 4.1. Transdermal Drug Delivery Solutions Impact Pain, Neurological and Hormonal Indications
    • 4.1.1. Phase 1 Clinical Trial Assessment Shows Active Research Across Therapeutic Areas
    • 4.1.2. Phase 2 Clinical Trial Assessment Shows Active Research Across Transdermal Cancer and Hormonal Therapy
    • 4.1.3. Phase 3 Clinical Trial Assessment Shows Active Research for Transdermal Neurological Therapy
    • 4.1.4. Key Transdermal Therapy Clinical Trials Across Phases
    • 4.2.1. Active Industry Partnerships and Alliances in Transdermal Drug Delivery Industry
    • 4.2.2. Microneedle Technology Licensed from Universities
    • 4.2.3. Transdermal Technologies Licensed for by Key Companies
    • 4.3.1. Funding Assessment Indicates Market Interest Toward Microneedle Technology
    • 4.3.2. National Institute of Allergy and Infectious Diseases is the Top Funding Federal Agency for Transdermal Drug Delivery
    • 4.3.3. Key Federal Funded Research Projects for Transdermal Drug Delivery

5.0. Growth Opportunities & Strategic Insights

  • 5.1. Transdermal Drug Delivery Industry Innovation Ecosystem: Key Innovators
    • 5.2.1. Growth Opportunities: Advanced Microneedles
    • 5.2.2. Growth Opportunities: Transdermal Gene Delivery
    • 5.2.3. Growth Opportunities: Smart Transdermal Patches
    • 5.3.1. Technology Roadmap of the Transdermal Drug Delivery Industry
    • 5.3.2. Technology Roadmap Overview
    • 5.3.3. Technology Roadmap of the Transdermal Drug Delivery Industry (Legend)
    • 5.3.4. Technology Roadmap of the Transdermal Drug Delivery Industry - Explained
  • 5.4. Technology Convergence for Advanced Transdermal Drug Delivery
  • 5.5. Emerging Cross Cluster Technologies are Set to Revolutionize the Future Transdermal Drug Delivery Industry
  • 5.6. Strategic Recommendations for Transdermal Drug Delivery Industry Growth

6.0. Key Industry Contacts

  • 6.1. Key Industry Contacts
  • 6.1. Key Industry Contacts (continued)
  • Legal Disclaimer
Back to Top